Aviir - Diagnosing Cardiovascular Disease

Assay Development and Commercialization

Success Story


Aviir wanted to reduce costs, reduce sample, and bridge the gap of working on two separate platforms.

Their Story

AVIIR is a biotechnology company that develops cutting-edge, diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease. The company’s proprietary technology is based on years of research and combines the founder’s deep understanding of biomarker assay development and advanced biostatistics.

Their Objective

Using MSD and Luminex multiplex platforms, AVIIR developed a lab derived test that incorporated the levels of seven unique biomarkers. These markers, along with physiological metrics such as age, sex, and BMI provide a risk score that correlated with a 5-year risk factor of a cardiac event caused by a lesion. This score would be used by a physician to counsel and advise patients to achieve lower cardiac event risks. Due to license fees and the high cost of running tests on two separate systems, AVIIR needed to simplify their process into a single assay.

The Solution

Quansys Biosciences would create a single multiplex kit that needed to exceed the current individual performance specifications of each of the MSD and Luminex platforms. The solution needed to fit within the current regulatory environment of a lab-derived test and meet automation requirements for high throughput.


AVIIR provided Quansys with required specifications for the lab derived test and Quansys acquired the necessary antibodies, calibrators and controls to develop and build a 7-plex product that had superior reproducibility along with improved sensitivity.

  • Eliminate Licence Fees. Using Q-Plex technology allowed AVIIR to eliminate the cost of licensing software, and other analyte technology.

  • Reduce Sample. By only using one assay to run the required 7 analytes, AVIIR was able to reduce sample required – minimizing the complexity and cost of specimen collection, sample preparation, and testing time.

  • Simplifyy. Q-Plex Technology allowed AVIIR to multiplexing seven analytes on one platform, greatly simplifying the diagnostic process which has saved AVIIR time and money.

Services Used


Assay Development

ISO 13485 development of sensitive arrays.

Learn More

Analytical Software

Easy and powerful access to data. 

Learn More


Quality imaging from the most affordable systems.

Learn More

Custom Assay Printing

Your Markers Multiplexed

Learn More

We are Committed to Your Success

As researchers and problem solvers ourselves, we understand the value of sound data. We are proud to be a part of research that can better the world. We value the relationships, partnerships, and friendships that we have built with the people who trust and use our technology. We are committed to building these relationships. You can count on us to answer the phone and take time to thoroughly address questions or concerns about any of our products. In an industry that is reputed for grandiose claims, we trust that our quality standards and our customer service set us apart from the competition. If you’re happy with our products or if you think we can do something better we hope you will let us know.



365 N 600 W, Logan, UT